Processa Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Processa Pharmaceuticals Inc.
Former names: Heatwurx, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Vero Beach
Headquarters state / province: Florida
Headquarters country: United States
Fiscal year end: December
Ticker symbol: PCSA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001533743
EIN: 45-1539785

Board of directors

Follow this board

David Young · Director · Pres. Research & Development
Since 2023
George K. Ng · Director · Chief Executive Officer
Since 2023
Geraldine Pannu · Director
Since 2023
James R. Neal · Director
Since 2023
Justin W. Yorke · Director
Since 2023
Khoso Baluch · Director
Since 2023
Sheila Gujrathi · Director
Since 2026
Virgil Thompson · Director
Since 2023

Chief executives

David Young · President & CEO

Dates unknown

George K. Ng · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of July 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Justin W. Yorke

100.0%
George K. Ng

100.0%
Khoso Baluch

100.0%
James R. Neal

100.0%
Geraldine Pannu

100.0%
David Young

100.0%

Board connections

6 of this board's directors also sit on 10 other boards. 8 are in the same sector.

Shared director Other board Same sector

Akari Therapeutics plc Same sector
via James R. Neal
BlossomHill Therapeutics Inc. Same sector
via Sheila Gujrathi
Bolt Biotherapeutics Inc. Same sector
via Sheila Gujrathi
Calidi Biotherapeutics Inc. Same sector
via George K. Ng
Endovia Health Sciences Inc.
via Justin W. Yorke
Janux Therapeutics Inc. Same sector
via Sheila Gujrathi
Longeveron Inc. Same sector
via Khoso Baluch
Palisade Bio Inc. Same sector
via James R. Neal
RBB Bancorp
via Geraldine Pannu
TuHURA Biosciences Inc. Same sector
via George K. Ng

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $203,250; 41 purchases by 9 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 8, 2026	George K. Ng Director, Officer (Chief Executive Officer)	Option exercise	+1,600	—	—
Jul 1, 2026	George K. Ng Director, Officer (Chief Executive Officer)	Open-market purchase	+3,057	$1.93	$5,900
Jun 30, 2026	Guy Wendy Officer (Chief Administrative Officer)	Open-market purchase	+2,436	$1.93	$4,701
Jun 30, 2026	Lin Patrick Officer (Chief Business - Strategy Off)	Open-market purchase	+2,106	$1.93	$4,065
Jun 30, 2026	David Young Director, Officer (Pres. Research & Development)	Open-market purchase	+2,531	$1.93	$4,885
Jun 30, 2026	SKIBSTED RUSSELL Officer (Chief Financial Officer)	Open-market purchase	+3,277	$1.93	$6,325
Jun 26, 2026	Justin W. Yorke Director	Option exercise	+203	—	—
Jun 26, 2026	Geraldine Pannu Director	Option exercise	+203	—	—
Jun 26, 2026	James R. Neal Director	Option exercise	+203	—	—
Jun 26, 2026	Khoso Baluch Director	Option exercise	+203	—	—
Jun 15, 2026	David Young Director, Officer (Pres. Research & Development)	Open-market purchase	+2,067	$2.22	$4,589
Jun 15, 2026	SKIBSTED RUSSELL Officer (Chief Financial Officer)	Open-market purchase	+2,654	$2.22	$5,892
Jun 15, 2026	George K. Ng Director, Officer (Chief Executive Officer)	Open-market purchase	+2,465	$2.22	$5,472
Jun 15, 2026	Lin Patrick Officer (Chief Business - Strategy Off)	Open-market purchase	+1,831	$2.22	$4,065
Jun 15, 2026	Guy Wendy Officer (Chief Administrative Officer)	Open-market purchase	+2,118	$2.22	$4,702

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Processa Pharmaceuticals Inc.

Who is the CEO of Processa Pharmaceuticals Inc.?

David Young is Processa Pharmaceuticals Inc.'s President & CEO.

How many directors are on Processa Pharmaceuticals Inc.'s board?

Processa Pharmaceuticals Inc.'s board has 8 directors: David Young, George K. Ng, Geraldine Pannu, James R. Neal, Justin W. Yorke, Khoso Baluch, Sheila Gujrathi and Virgil Thompson.

Are Processa Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, Processa Pharmaceuticals Inc. insiders bought $203,250 of shares in 41 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Processa Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="processa-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.